Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • How Our Journey Began
    • News →
      • Latest News
      • Research News
      • Foundation News
      • UCLA Activity Summary Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • Seed Grant News
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • UC Pancreatic Cancer Consortium
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Where to Begin
    • Caregivers & Families
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Resources →
      • NCCN Guidelines for Patients
      • Patient Support Tools
      • Create Your Health Care Team
      • Patient Health Diaries
      • Support Groups
      • Financial Aid
  • HOW YOU CAN HELP
    • Planned Giving
    • Donor-Advised Funds
    • Event Calendar
    • Get Inspired
    • Fundraising Resources
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • More Ways to Give →
      • You Can Help Funds
      • Host Your Own Event
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Car Program
  • SEARCH
Home / News / Symposium Speaker Spotlight: Jon King, MD to discuss Surgical Treatment of Pancreatic Cancer: A Moving Target

Symposium Speaker Spotlight: Jon King, MD to discuss Surgical Treatment of Pancreatic Cancer: A Moving Target

Jon King, MD, to present Surgical Treatment of Pancreatic Cancer: A Moving Target at our 19th Annual Symposium on Pancreatic Cancer

February 5, 2025

The Hirshberg Foundation is excited to announce that Dr. Jon King will be joining us at the 19th Annual Symposium on Pancreatic Cancer to discuss the evolving nature of surgical treatments for pancreatic cancer.

Surgery is a cornerstone of treatment for pancreatic cancer that has not spread outside of the primary (main) tumor. While surgery to remove most pancreatic tumors is complex and has historically been associated with poor outcomes, improvements in pancreatic surgery in the past 40 years have made surgery reliably safe for nearly all patients. More recent advances have brought minimally-invasive techniques, complex vascular (blood vessel) resection/reconstruction, and enhanced recovery after surgery into routine clinical use. These, along with effective chemotherapies that are frequently applied before surgery, means that more and more patients are candidates for surgery today than ever before.

Dr. Jonathan King is an Associate Professor in the Division of General Surgery at UCLA. He attended the University of Maryland for his M.D. degree before coming to UCLA for his general surgery residency. After residency, Dr. King spent two years in Pittsburgh, PA (UPMC) for a surgical oncology fellowship before returning to Los Angeles to join the surgery faculty. He is board certified in General Surgery as well as Complex Surgical Oncology and has particular interest in pancreatic cancer and disseminated peritoneal malignancies. He has expertise in robotic-assisted minimally invasive pancreas surgery and performed UCLA’s first minimally-invasive pancreaticoduodenectomy (Whipple procedure). He also started UCLA’s program for hyperthermic intraperitoneal chemoperfusion (HIPEC).

In addition to his clinical interests Dr. King has authored numerous peer-reviewed manuscripts and abstracts as well as book chapters in some of the authoritative surgical textbooks. Dr. King is an enthusiastic surgical educator and is developing the UCLA residency training curriculum for robotic-assisted surgery and he is a member of numerous professional societies.

A valuable presentation for our pancreatic cancer community; we are so happy to have Dr. King present the Surgical Treatment of Pancreatic Cancer: A Moving Target at the 19th Annual Symposium.

image_pdfimage_print

Filed Under: Foundation News, News, Symposium Speaker Spotlight

Symposium Speaker Spotlight: Barbara Demman to present Empowering Pancreatic Cancer Patients with Mindfulness
Symposium Speaker Spotlight: Emily Martin, MD, to discuss Navigating Your Pancreatic Cancer Treatment Right From The Start

Patient Support Resources

from the comfort of your home


Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Financial Information
  • Contact